Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01046929 · ClinicalTrials.gov registry record · Phase 1
Limonene Study in Women With Breast Cancer
A Phase 1 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 1
- Development phase
- 59
- Enrollment target
NCT01046929 is a Phase 1 study that has completed, run by University of Arizona. The registered enrollment target is 59 participants.
The verdict
NCT01046929, a Phase 1 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 59 participants
- Enrollment target
Study Summary
Limonene is a major component in the essential oils of citrus fruits. It has demonstrated promising breast cancer preventive and therapeutic effects in preclinical model systems. This early phase clinical study will evaluate the distribution of limonene to the breast tissue and its associated biological activities after 2 to 6 weeks of limonene dosing in women with a recent diagnosis of early stage breast cancer. This study will help evaluate the potentials of developing limonene as a breast cancer preventive agent.
Interventions
- DIETARY_SUPPLEMENT limonene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01046929
The ClinicalTrials.gov registry entry for NCT01046929 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which limonene is the first listed.
NCT01046929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01046929 about?
NCT01046929 is a clinical study titled "Limonene Study in Women With Breast Cancer". Limonene is a major component in the essential oils of citrus fruits. It has demonstrated promising breast cancer preventive and therapeutic effects in preclinical model systems. This early phase clinical study will evaluate the distribution of limonene to the breast tissue and its associated biolog...
What is the current status of trial NCT01046929?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 59 participants. The study started on 2009-08. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01046929?
The interventions under investigation include: limonene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01046929?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.